Reply to Roberto Mario Scarpa’s Letter to the Editor: Sham or Active Control in MIST Trials? A False Methodological Dichotomy. re: Baboudjian M, Nunzio C, Elterman D, et al. What is the Standard Comparator of Minimally Invasive Surgical Therapies (MIST) for Benign Prostatic Obstruction? Medical Versus Surgical Treatment. Eur Urol. 2026 Aug;90(2):95-97.
Reply to Roberto Mario Scarpa’s Letter to the Editor: Sham or Active Control in MIST Trials? A False Methodological Dichotomy. re: Baboudjian M, Nunzio C, Elterman D, et al. What is the Standard Comparator of Minimally Invasive Surgical Therapies (MIST) for Benign Prostatic Obstruction? Medical Versus Surgical Treatment. Eur Urol. 2026 Aug;90(2):95-97. // European Urology. – URL: https://www.sciencedirect.com/science/article/pii/S0302283826024309?dgcid=rss_sd_all
Reply to Roberto Mario Scarpa’s Letter to the Editor: Sham or Active Control in MIST Trials? A False Methodological Dichotomy. re: Baboudjian M, Nunzio C, Elterman D, et al. What is the Standard Comparator of Minimally Invasive Surgical Therapies (MIST) for Benign Prostatic Obstruction? Medical Versus Surgical Treatment. Eur Urol. 2026 Aug;90(2):95-97. European Urology. https://www.sciencedirect.com/science/article/pii/S0302283826024309?dgcid=rss_sd_all
“Reply to Roberto Mario Scarpa’s Letter to the Editor: Sham or Active Control in MIST Trials? A False Methodological Dichotomy. re: Baboudjian M, Nunzio C, Elterman D, et al. What is the Standard Comparator of Minimally Invasive Surgical Therapies (MIST) for Benign Prostatic Obstruction? Medical Versus Surgical Treatment. Eur Urol. 2026 Aug;90(2):95-97.” European Urology.
@article{article93863,
title = {Reply to Roberto Mario Scarpa’s Letter to the Editor: Sham or Active Control in MIST Trials? A False Methodological Dichotomy. re: Baboudjian M, Nunzio C, Elterman D, et al. What is the Standard Comparator of Minimally Invasive Surgical Therapies (MIST) for Benign Prostatic Obstruction? Medical Versus Surgical Treatment. Eur Urol. 2026 Aug;90(2):95-97.},
journal = {European Urology},
url = {https://www.sciencedirect.com/science/article/pii/S0302283826024309?dgcid=rss_sd_all}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...